ClearPoint Neuro (CLPT): Company Cash Volume

Official company branding of ClearPoint Neuro (CLPT)

ClearPoint Neuro, Inc. (CLPT) is actively implementing navigation systems for the precise delivery of gene therapy to the brain. This high-tech MRI-controlled ecosystem creates strong clinic lock-in to the vendor's software. Current cash reserves allow for a liquidity assessment, while the value of 0.05 shows the most recent figure. Service scalability is driven by cloud data storage and contract manufacturing of hardware modules.

Company Cash Funds: ClearPoint Neuro (CLPT) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for clearpointneuro.com (CLPT)

- stock exchange capitalization data:
Initial company analysis:ClearPoint Neuro Inc. CLPT
Brand item of ClearPoint Neuro, Inc.

This indicator determines the volume of available liquidity, representing the net value of the company's cash holdings. By analyzing the cash level metric, an investor tracks the daily dynamics of cash balances, eliminating the risk of reporting manipulations prior to M&A transactions. The metric measures the physical capital reserve capable of either fueling growth or masking stagnation. For ClearPoint Neuro, Inc. (CLPT), such reserves are critical when scaling neuronavigation systems amid rising demand in gene therapy.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume TNDM (Tandem Corp)|Company Cash Funds axogeninc.com|Company Cash on Hand SI-BONE, Inc. (SIBN)|Company Cash Volume OFIX|Bioventus Corp - Company Cash and Cash Equivalents|Company Cash Funds orthopediatrics.com KIDS|TMCI: Company Cash and Cash Equivalents|SRTA: Company Cash on Hand|Carlsmed Inc - Company Total Cash Amount|RxSight (RXST) - Company Cash Funds|STXS - Company Liquid Assets|STIM (neurostar.com) - Company Cash Volume|Sight Sciences, Inc (SGHT) - Company Liquid Assets|Company Cash Volume OBIO|Company Liquid Assets Anika Therapeutics Inc.|Company Cash Funds InspireMD, Inc. NSPR|Company Cash Balance ZJYL|VANI - Company Cash Funds|Xtant Medical Holdings, Inc. - Company Total Cash Amount|NeuroOne (NMTC) - Company Cash Funds|Modular Med (MODD) - Company Cash Volume|Company Cash Funds Myomo, Inc|Company Cash on Hand Envoy Medical (COCH)|Company Cash Volume VVOS|NVNO (enVVeno Corp) - Company Cash Balance|Company Cash Volume SINT (Sintx Technologies)|TNON: Company Cash and Cash Equivalents|Lifeward - Company Cash Volume|Company Cash Balance AMIX (Autonomix Medical)|IVF: Company Cash Volume|Company Cash Position Bone Biologics Corporation BBLG|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)